Verrica Pharmaceuticals Inc.
VRCA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$274 | $204 | -$9,742 | -$16,202 |
| Dep. & Amort. | $184 | $118 | $208 | $253 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $718 | $888 | $1,026 | $756 |
| Change in WC | $7,933 | -$11,607 | -$4,586 | -$4,091 |
| Other Non-Cash | $1,124 | $353 | $417 | $3,220 |
| Operating Cash Flow | $9,685 | -$10,044 | -$12,677 | -$16,064 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $8 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,984 | -$4,155 | -$4,057 | -$1,514 |
| Stock Issued | $0 | $0 | $0 | $39,637 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $1,303 |
| Financing Cash Flow | -$3,984 | -$4,155 | -$4,057 | $39,426 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $5,701 | -$14,199 | -$16,734 | $23,370 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,396 | $29,595 | $46,329 | $22,959 |
| End Cash | $21,097 | $15,396 | $29,595 | $46,329 |
| Free Cash Flow | $9,685 | -$10,044 | -$12,677 | -$16,064 |